Investment Rating - The report suggests a "core + satellite" investment strategy focusing on structural investment opportunities in the aerospace and defense industry [1][9]. Core Insights - Structural investment opportunities exist in the chain reaction of orders, particularly in combat-driven ammunition replenishment, upstream supplier value highlighted by production bottlenecks, and direct commercial procurement (DCS) representing future warfare [1][9]. - The most certain short-term demand is for interceptor missile replenishment worth over $1 billion, with significant revenue potential for companies like RTX [2][10]. - Production bottlenecks create investment flexibility for key upstream companies, making them more attractive than prime contractors [3][11]. Summary by Sections Ammunition Replenishment - The consumption of defensive interceptor missiles has the highest certainty and urgency for replenishment, with potential revenue of nearly $1 billion for RTX from ammunition replenishment alone [2][10]. - The report highlights specific ammunition types and their estimated consumption and replenishment values, such as the Iron Dome's Tamir interceptor with a replenishment value of $750 million to $1 billion [3]. Production Bottlenecks - Delivery cycles of 1-2 years for munitions like JDAM indicate a stable revenue stream for defense contractors, enhancing performance visibility [3][11]. - The report outlines production capacities and delivery timelines for various ammunition types, emphasizing the limited capacity and high demand [4]. Direct Commercial Procurement (DCS) - The DCS channel indicates a shift towards more flexible and cost-effective combat capabilities, opening new growth opportunities for companies focused on unmanned systems, AI data analysis, and cybersecurity [5][12]. - Recent DCS orders highlight the strategic intent of the Israeli defense sector to invest in advanced technologies, benefiting companies specializing in these areas [6]. Investment Recommendations - The report recommends focusing on companies such as BAE Systems, Howmet Aerospace, Lockheed Martin, Boeing, RTX, Rheinmetall, and Woodward for potential investment opportunities [13].

[Table_Title] 研究报告 Research Report 18 Jun 2025 VISA VISA (V US) 稳定币冲击 VISA，影响几何？ The Stablecoins Challenge to VISA 寇媛媛 Yuanyuan Kou 陈芳园 Ashley Chen yy.kou@htisec.com ashley.fy.chen@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) 近日 VISA 股价出现显著波动，我们认为市场担忧大型零售平台发行稳定币可能影响支付生态，对 VISA 等传统支付 网络构成潜在冲击，是此次股价下行的主要诱因。自 6 月 13 日《华尔街日报》发布《Walmart 和 Amazon 正在探 索发行自己的稳定币》以来，市场对大型零售平台可能重构支付生态的担忧迅速升温，支付类股票集体承压。其 中，行业龙头 VISA 和 Mastercard 分别下跌 5.4%和 4.6%。投资者担心，若平台型稳定币 ...

Investment Rating - The report rates the pharmaceutical industry as "Outperform" [1][2] - The sub-industries of pharmaceutical manufacturing and pharmaceutical services are also rated as "Outperform" [2] Core Insights - Continuous recommendation of innovative drugs and devices, with a positive outlook on companies such as Jiangsu Heng Rui Medicine, Hansoh Pharmaceutical, Sichuan Kelun Pharmaceutical, Huadong Medicine, 3SBio, CSPC Pharmaceutical Group, and Changchun High-tech Industry [4][23] - The report emphasizes that centralized procurement optimization is expected to benefit innovative drugs and devices, as highlighted in a State Council meeting on June 13, 2025 [24] - The A-Shares pharmaceutical sector outperformed the market in the second week of June 2025, with a 1.4% increase compared to a 0.2% decrease in the Shanghai Composite Index [6][25] - The Hong Kong and U.S. pharmaceutical sectors also outperformed the market during the same period, with significant gains in the Hang Seng Healthcare and Biological Technology indices [20][26] Summary by Sections Continuous Recommendation of Innovative Drugs and Devices - The report maintains a positive outlook on innovative drugs, highlighting the potential for value re-evaluation in companies like Heng Rui Medicine, Hansoh Pharmaceutical, and others [4][5] - Biopharma/Biotech companies such as Kelun Biotech, Innovent Biologics, and BeiGene are also recommended for their growth potential [4][5] Performance of A-Shares Pharmaceutical Sector - In the second week of June 2025, the A-Shares pharmaceutical sector rose by 1.4%, ranking 4th among Shenwan primary industries [6][25] - Notable individual stock performances included Tibet Aim Pharm. Inc. (+38.5%) and Beijing Science Sun Pharmaceutical (+36.4%) [25][14] Performance of Hong Kong and U.S. Pharmaceutical Sectors - The Hang Seng Healthcare index increased by 8.8%, and the Biological Technology index rose by 10.5% during the same period [20][26] - In the U.S., the S&P 500 Healthcare Select Sector rose by 1.2%, with top gainers including Regeneron (+7%) and Eli Lilly (+6%) [20][26]

Investment Rating - The report assigns an "Outperform" rating to ADNOC Distribution, indicating an expected relative return exceeding 10% over the next 12-18 months [19]. Core Insights - ADNOC Distribution is recognized for its differentiated retail model, focusing on shareholder cash returns and strategic expansion in customer base and property management [2][3]. - The company is expanding its non-fuel retail business, which contributes nearly 10% of total retail revenue but has the highest profit margins, maintaining a gross margin of over 50% [4]. - The company aims to increase its electric vehicle (EV) charging points significantly, targeting a 10-15 times increase by FY28 compared to FY23 [4]. - Expansion into Saudi Arabia and Egypt is seen as crucial for mid-term growth, leveraging a light-asset model to increase station numbers in these markets [4]. Company Overview - ADNOC Distribution operates primarily in the UAE, with a presence in Saudi Arabia and Egypt, and is 77% owned by the ADNOC Group [3]. - As of the end of FY24, the company operates 896 fuel stations, with a goal of reaching 1,000 by FY28 [3]. - The company also manages 373 ADNOC Oasis convenience stores and provides various services including car inspections and EV charging [3]. Financial Performance - The company's dividend policy is attractive, with plans to distribute $700 million or at least 75% of net profits as dividends from FY24 to FY28, translating to an approximate 6.0% dividend yield [5].

Investment Rating - The report maintains an "Outperform" rating for the company [4][12]. Core Insights - The company is projected to achieve revenues of $325 million, $361 million, and $410 million for 2025, 2026, and 2027 respectively, reflecting year-over-year growth rates of 8.81%, 11.12%, and 13.45% [5][12]. - The first quarter of 2025 showed strong performance with revenues of $74.70 million, a 21.1% increase year-over-year, driven by growth in IoT PaaS, SaaS, and Smart Solutions [5][12]. - The company has embraced AI, launching four core engines that enhance its platform capabilities, which are expected to support large-scale AI product deployment [5][12]. Financial Summary - Revenue projections for the company are as follows: 2025E at $325 million, 2026E at $361 million, and 2027E at $410 million, with corresponding growth rates of 8.8%, 11.1%, and 13.5% [3][5]. - The gross profit margin for Q1 2025 was reported at 48.5%, an increase of 0.7 percentage points year-over-year, with a net profit of $11 million compared to a loss of $3.5 million in Q1 2024 [5][12]. - The company has a cash and cash equivalents balance of $1.02 billion as of Q1 2025 [5][12]. Customer and Market Dynamics - As of Q1 2025, the company has a total of 2,800 customers, with 2,000 on the IoT PaaS platform, and premium users contributing 88.7% of IoT PaaS revenue [5][12]. - The company's developer platform has reached 1.417 million developers, indicating strong customer stickiness and potential for global IoT standard expansion [5][12].

Investment Rating - The report maintains an "Outperform" rating for the company with a target price of 33.40 RMB [1][6][10] Core Insights - The integration of digital intelligence business significantly enhances the company's profitability, with projected revenues for 2025-2027 at 8.91 billion, 9.69 billion, and 10.69 billion RMB, reflecting year-on-year growth of 147.73%, 8.83%, and 10.26% respectively [6][10] - The net profit attributable to shareholders is expected to reach 170 million, 238 million, and 292 million RMB for the same period, showing substantial growth of 1669.83%, 40.08%, and 22.67% [6][10] - The company's cash generation ability is rapidly recovering due to the expansion of standardized products in cybersecurity, cost control measures, and the merger with AsiaInfo Technologies [3][10] Financial Summary - In 2024, the company achieved a revenue of 3.60 billion RMB, a year-on-year increase of 123.56% [6][10] - The gross profit margin in 2024 was 51.61%, up 3.79 percentage points, primarily due to the increased revenue share from standardized products in cybersecurity [6][10] - The net profit attributable to shareholders in 2024 was 9.59 million RMB, with the cybersecurity segment reporting a loss of 90.68 million RMB, while the digital intelligence segment turned profitable at 100 million RMB [6][10] Product and Market Insights - The company's standardized product revenue grew by 7.4% year-on-year, accounting for 47.3% of the cybersecurity revenue, with a gross margin of 61.35%, an increase of 13.53 percentage points [3][10] - The HarmonyOS is expected to positively impact the company's terminal security business, which is a core product line, enhancing growth in both existing and new markets [6][10]

Investment Rating - The report initiates coverage with an "Outperform" rating, setting a target price of 29.21 RMB based on the growth potential from AI-native agents and computing power services [1][17][42]. Core Insights - The company, established in 2003, is a seasoned fintech and data center service provider with a focus on AI technologies, serving financial institutions, government, utilities, and enterprises [43]. - The AI-native architecture is expected to unlock new enterprise AI markets, enhancing business models and improving ROI, with projected AI revenue of 208 million RMB in 2024 and signed orders of 293 million RMB [44]. - The company is leveraging its data center services to expand its computing power business, with anticipated revenue of 297 million RMB in 2024 and orders totaling 557 million RMB [45]. Financial Summary - The company forecasts revenue growth from 1,002 million RMB in 2023 to 1,684 million RMB in 2025, representing a year-on-year increase of 44.3% [2][10]. - Net profit is expected to improve from a loss of 108 million RMB in 2023 to a profit of 46 million RMB by 2027, with a significant year-on-year growth of 268.6% in 2026 [2][10]. - The earnings per share (EPS) are projected to transition from -0.32 RMB in 2023 to 0.14 RMB in 2027 [2][10]. Business Segmentation - The company operates in three main segments: fintech, artificial intelligence, and data center services. The fintech segment is expected to grow at a rate of 30% annually from 2025 to 2027, driven by strong customer retention and AI product integration [7][9]. - The artificial intelligence segment is projected to grow at 70% in 2025, 55% in 2026, and 35% in 2027, supported by a robust order pipeline [7][9]. - The data center segment is anticipated to grow at 60% in 2025, 40% in 2026, and 20% in 2027, benefiting from increased demand for computing power [7][9]. Margin and Profitability - The overall gross margin is expected to improve from 19.3% in 2024 to 22.0% by 2027, reflecting the scaling of AI products and decreasing marginal costs [8][10]. - The company aims to enhance its profitability metrics, with a projected return on equity (ROE) improving from -5.7% in 2023 to 2.4% in 2027 [2][10].

Investment Rating - The report maintains an "Outperform" rating for the company with a target price of RMB 38.97 [1][10]. Core Insights - The company is experiencing steady improvement in operational quality, with AI products and services achieving breakthrough growth, leading the intelligent transformation in the industrial software sector [1][10]. - The forecast for EPS is RMB 0.97 for 2025, RMB 1.26 for 2026, and RMB 1.65 for 2027, with a forward PE of 40x assigned for 2025 [10][11]. Financial Summary - Revenue is projected to grow from RMB 1.405 billion in 2023 to RMB 2.485 billion by 2027, reflecting a CAGR of approximately 20.1% [3][5]. - Net profit attributable to shareholders is expected to fluctuate, with a decline to RMB 192 million in 2024, followed by a recovery to RMB 403 million by 2027 [3][5]. - The company’s operating cash flow improved significantly, reaching RMB 519 million in 2024, a 64.87% increase [11]. Business Segments - AI products and services revenue is forecasted to surge from RMB 273 million in 2024 to RMB 1.032 billion by 2027, with an impressive growth rate of 1255.99% in 2024 [8][12]. - The cloud products and services segment is expected to grow steadily, with revenue increasing from RMB 458.24 million in 2024 to RMB 626.66 million by 2027 [8]. - The industrial engineering and electrical products segment is projected to grow from RMB 456.50 million in 2024 to RMB 658.53 million by 2027 [8]. Competitive Positioning - The company is focusing on optimizing its self-developed "Le Series" industrial software, enhancing its core competitiveness with 12 industry packages and 156 industrial components [13]. - The launch of the "Ling Series" AI agent aims to address various industry needs, showcasing the company's commitment to leading the digital and intelligent ecosystem in the industrial sector [12][13].

Investment Rating - The report maintains an "Outperform" rating for the company [2][14]. Core Insights - The company is experiencing high revenue growth and significant cash flow optimization, driven by its AI+SaaS ecosystem, which is facilitating breakthroughs in both small and medium-sized enterprises (SMB) and key accounts (KA) markets [2][16]. - The commercialization of AI agents is accelerating, contributing to sustained performance growth for the company [2][16]. Financial Summary - The company’s revenue is projected to grow from 1.56 billion RMB in 2024 to 4.33 billion RMB by 2027, reflecting a compound annual growth rate (CAGR) of 51.9% from 2025 to 2027 [4][7]. - The net profit attributable to shareholders is expected to improve significantly, moving from a loss of 0.04 million RMB in 2025 to a profit of 3.50 million RMB by 2027, indicating a growth rate of 3615.8% in 2026 [4][7]. - The operating cash flow is expected to turn positive, with a net inflow of 138 million RMB in 2024, compared to a negative cash flow of 122 million RMB in the previous year [4][16]. Business Segments - The company’s SaaS business is anticipated to generate revenue of 1.14 billion RMB in 2025, with a growth rate of 35.0% and a gross profit margin of 85.0% [8][10]. - The precision marketing service segment is projected to achieve revenue of 931 million RMB in 2025, with a growth rate of 30.0% and a gross profit margin of 13.5% [10][11]. - The newly introduced Agent integrated machine is expected to generate 300 million RMB in revenue in 2025, with a gross profit margin of 42.0% [10][11]. Valuation - The target price for the company is set at 82.80 HKD, based on a sum-of-the-parts (SOTP) valuation method, reflecting a total market value of approximately 212.19 billion HKD [14][16].

Investment Rating - The report maintains an "Outperform" rating for the company with a target price of 53.46 RMB, based on a projected 30x PE for 2025 [1][9]. Core Insights - The company's profitability is expected to recover in 2025, with projected revenues of 1.34 billion RMB in 2025, growing at 18.56% YoY, and net profit attributable to shareholders at 0.23 billion RMB, growing at 16.98% YoY [3][10]. - The demand for coal mine intelligence is a strong driver for growth, as the company develops software and hardware solutions that enhance safety and efficiency in mining operations [11]. - The company is expanding into non-coal mining, chemical sectors, and underground autonomous driving, which are in early stages but present significant growth potential [12]. Financial Summary - Revenue projections for 2025-2027 are 1.34 billion RMB, 1.57 billion RMB, and 1.82 billion RMB, respectively, with net profits of 0.23 billion RMB, 0.28 billion RMB, and 0.33 billion RMB [3][9]. - The company reported a revenue of 1.13 billion RMB in 2024, a 12.05% increase YoY, while net profit attributable to shareholders was 0.20 billion RMB, a decrease of 10.56% YoY [10]. - The first quarter of 2025 showed a revenue of 0.25 billion RMB, up 10.41% YoY, with net profit attributable to shareholders at 41.94 million RMB, an increase of 14.64% YoY [10].